Steven Fusco is the CEO and President of OcuSynex, a next-generation medical communications and commercialization partner designed to accelerate the journey from early scientific innovation to successful product launch. With a career spanning strategic accounts, clinical development support, and pharmaceutical commercialization, Steven brings a uniquely integrated, end-to-end perspective to the life sciences industry.
Steven's career has been built at the intersection of science and execution. Currently serving as Senior Director of Strategic Accounts at Harrow, he plays a key role in driving national commercial strategy, collaborating across marketing, sales, and leadership teams to execute high-impact initiatives including innovative access models such as direct-to-prescriber pharmaceutical programs.
Prior to this, Steven held leadership roles across organizations including ImprimisRx, Lexitas Pharma Services, Santen, and Eyevance Pharmaceuticals, where he consistently drove top-line revenue growth, built and managed strategic relationships with key opinion leaders and large healthcare systems, and supported the advancement and commercialization of ophthalmic therapies. His experience spans the full product lifecycle, from early-stage development support and clinical trial alignment to market access and commercial execution.
In parallel with his corporate leadership, Steven is a serial entrepreneur and Co-Founder of MYZE, a digitally native patient engagement platform focused on transforming the eye care journey through continuous, personalized care. This entrepreneurial experience reflects his deep commitment to improving patient outcomes by rethinking how therapies are delivered, supported, and adopted in real-world settings.
As CEO of OcuSynex, Steven has built a differentiated model that integrates medical writing, early development strategy, clinical trial execution through CRO partnerships, and a cutting-edge contract commercial infrastructure. His vision is rooted in a simple but powerful belief: that scientific innovation only creates value when it is effectively translated, executed, and brought to market with precision.
Steven's leadership is defined by his ability to connect strategy with execution, aligning scientific storytelling, clinical development, and commercial performance into one cohesive pathway. He is recognized for building high-performing teams, exceeding revenue targets, and delivering measurable results in complex, competitive healthcare environments.
He holds a Bachelor of Business Administration from Pace University's Lubin School of Business and has been recognized for his performance with honors including several individual contributor Presidents Club Awards, Sales Manager of the Year, and Fairfield County's 40 under 40 Award.
Through OcuSynex, Steven continues to partner with emerging and established biopharma companies to transform promising ideas into clinically validated and commercially successful therapies.